Advances in Antiviral Research

1.  Antivirals: approaches and the way forward.- 2. Bioinformatics databases and tools available for the development of antiviral drugs.- 3. Developments in computer-aided drug design for antiviral research.- 4. Organoids in antiviral research: potential and challenges.- 5. Metabolomics tools in antiviral research.- 6. Epigenetic- and epitranscriptomic- targeted reprogramming: novel targets for the development of broad-spectrum antivirals.- 7. Application of cryoelectron microscopy in antiviral research.- 8. Host directed antiviral therapy.- 9. Role of herbal formulations in antiviral therapy - an overview.- 10. The use of animal models for antiviral therapeutics development: opportunities and challenges.- 11. In-vitro and in-vivo evaluation tools of SARS-CoV-2 antiviral drugs.- 12. Discovery of SARS-CoV-2 antiviral drugs through large-scale virtual screening of FDA-approved drugs.- 13. A high-throughput computational pipeline for selection of effective antibody therapeutics against viruses.- 14. Insights on various antiviral drugs for treating patients with COVID- 19.- 15. In ovo based antiviral assay for screening of  herbal formulations against Influenza viruses.- 16. The path to cure Hepatitis B: How far are we?.- 17. Unveiling emerging avenues in antiviral research: navigating clinical trials and regulatory landscapes.

Dr. Naveen Kumar is a Scientist at the National Institute of High Security Animal Diseases, Bhopal, India. He is an evolutionary biologist specialized in virus evolution and with a background in synthetic biology, molecular, and clinical virology. His primary research interests focus on viral genomics, nanoparticles-based diagnostics, therapeutics, and vaccines for emerging and re-emerging zoonotic viruses, primarily Influenza and SARS-CoV-2 viruses. He also employs selective genetic and evolutionary tools to comprehend the dynamics of virus evolution. He has been conferred with many prestigious honours, including the Young Scientist Award from the Indian Virological Society, the SERB-International Travel Grant for attending ASV-2018 at the University of Maryland in the United States, and the International Federation of Biosafety's Biorisk Management Certification. He had developed a number of diagnostic technologies, including one for which a patent has been granted onsynthetic-biology inspired diagnostics. He holds editorial positions in many international prestigious journals, such as Associate Editor of BMC Microbiology, Guest Associate Editor of Frontiers in Microbiology, Editorial Member of BMC Genomics and PLOS ONE, and Review Editor of Frontiers in Veterinary Science. He has served as a referee for a number of International journals, including Briefings in Bioinformatics (Oxford Academic), Scientific Reports (Nature), and Viruses (MDPI). He has also published more than 50 research articles in the peer-reviewed international journals and authored or co-authored numerous book chapters. He is a member of many national and international scientific societies and organizations importantly, American Society of Virology, Indian Virological Society, and Society of Biosafety, India.

Prof. Yashpal Singh Malik is currently the Dean of the College of Animal Biotechnology, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana,